ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Ophthalmology

Top Ophthalmology Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHANNES EVANS MD

Ophthalmology

4,826

$204K

1026
866 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

26%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 61%

$42
Average prescription price

Avg: $80

EDWARD HOLLAND MD

Ophthalmology

4,477

$548K

865
759 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 61%

$122
Average prescription price

Avg: $80

AARON PORTER MD

Ophthalmology

4,112

$385K

1056
874 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 61%

$94
Average prescription price

Avg: $80

MARK HENRY MD

Ophthalmology

3,846

$370K

912
781 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

78%
prescriptions for brand name drugs

Avg: 61%

$96
Average prescription price

Avg: $80

JAMES HUFFMAN MD

Ophthalmology

3,730

$248K

923
762 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 61%

$67
Average prescription price

Avg: $80

DAVID BLANDFORD MD

Ophthalmology

3,283

$123K

641
566 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 61%

$38
Average prescription price

Avg: $80

GREGORY SULKOWSKI M.D.

Ophthalmology

3,186

$268K

612
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 61%

$84
Average prescription price

Avg: $80

THOMAS KIM M.D.

Ophthalmology

3,106

$149K

639
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 61%

$48
Average prescription price

Avg: $80

SPENCER WITCHER MD

Ophthalmology

3,037

$254K

782
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 61%

$84
Average prescription price

Avg: $80

MARK HUFFMAN MD

Ophthalmology

2,942

$247K

836
705 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 61%

$84
Average prescription price

Avg: $80

DAVID KIELAR M.D.

Ophthalmology

2,739

$225K

393
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 61%

$82
Average prescription price

Avg: $80

WILLIAM CURTIS MD

Ophthalmology

2,735

$208K

599
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 61%

$76
Average prescription price

Avg: $80

JEAN NOLL M.D.

Ophthalmology

2,645

$209K

610
568 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 61%

$79
Average prescription price

Avg: $80

ALLEN ELLIOTT MD

Ophthalmology

2,588

$200K

428
351 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 61%

$77
Average prescription price

Avg: $80

CHARLES WHEELER M.D.

Ophthalmology

2,503

$161K

636
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 61%

$64
Average prescription price

Avg: $80

TOM MADDOX M.D.

Ophthalmology

2,364

$163K

569
532 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 61%

$69
Average prescription price

Avg: $80

MARK FITZMAURICE MD

Ophthalmology

2,360

$213K

531
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 61%

$90
Average prescription price

Avg: $80

TED BORODOFSKY M.D.

Ophthalmology

2,299

$198K

476
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 61%

$86
Average prescription price

Avg: $80

BARTON RAMSEY MD

Ophthalmology

2,290

$223K

427
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 61%

$97
Average prescription price

Avg: $80

JOERN SOLTAU M.D.

Ophthalmology

2,287

$133K

422
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 61%

$58
Average prescription price

Avg: $80

PAUL HERRELL MD

Ophthalmology

2,270

$189K

652
570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 61%

$83
Average prescription price

Avg: $80

STEVEN MATTAS MD

Ophthalmology

2,220

$152K

631
550 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 61%

$68
Average prescription price

Avg: $80

THOMAS FURGASON MD

Ophthalmology

2,210

$156K

521
450 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 61%

$71
Average prescription price

Avg: $80

SHEILA SANDERS MD

Ophthalmology

2,207

$158K

325
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 61%

$72
Average prescription price

Avg: $80

DAVID GARRETT MD

Ophthalmology

2,139

$132K

482
436 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 61%

$62
Average prescription price

Avg: $80

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank